Patents
Patents for C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272)
09/2007
09/26/2007CN100339380C Cucurbiturils and method for synthesis
09/26/2007CN100339379C 2-pyridinyl-6,7,8,9-tetrahydropyrimido{1,2-a}pyrimidin-4-one and 7-pyridinyl-1,3-dihydoimidazo{1,2-a}pyrimidin-5(1h)one derivatives
09/26/2007CN100339378C 6-2-(2-halogen-4-alkoxypenyl)-triazo-pyrimidine of killing fungus
09/26/2007CN100339354C Process for the preparation of chiral beta amino acid derivatives by asymmetric hydrogenation
09/26/2007CN100339080C Antiviral compounds
09/25/2007US7273936 A 2-pyridyl derivatives therapeutic agent for treating cancer, glomerulonephritis, diabetic nephropathy, hepatic fibrosis, pulmonary fibrosis, hyperplasia, restenosis, skin disorders
09/25/2007US7273878 Difluoroalkene derivative, pest control agent containing the same, and intermediate therefor
09/25/2007US7273869 P-(aminomethyl)phenyl-substituted pyrazoloquinoxalines, imidazoquinoxalines, triazoloquinoxalines and benzoquinoxalines, e.g., N,N-dimethyl-1-[4-(6-phenyl-1H-imidazo[4,5-g]quinoxalin-7-yl)phenyl]methanamine; serine/threonine protein kinase inhibitors for treating cancer
09/25/2007US7273868 excellent phosphodiesterase V (PDE V) inhibitory activity, and being useful as a remedy for the prophylaxis or treatment of penile erectile dysfunction with few side effects
09/25/2007US7273859 Spiro-alkane, -tetrahydrofuranfuran, -tetrahydropyran, -pyrrolidine or -piperidine fused ring pyrimidinonecarboxamides, e.g., N-[(4-fluorophenyl)methyl]-7',8'-dihydro-3'-hydroxy-4'-oxo-spiro[cyclopentane-21,9'(6'H)-[4H]pyrido[1,2- alpha ]pyrimidine]-2'-carboxamide
09/25/2007US7273603 Aerosol solutions containing fluorohydrocarbons and drug
09/20/2007WO2007106525A1 Piperidinyl, indolyl, pirinidyl, morpholinyl and benzimidazolyl urea derivatives as inhibitors of soluble epoxide hydrolase for the treatment of hypertension, inflammations and other diseases
09/20/2007WO2007106400A2 Pyridine-containing macroheterocylic compounds as kinase inhibitors
09/20/2007WO2007106144A1 NOR-SECO-, BIS-NOR-SECO, TRIS-NOR-SECO- AND HIGHER NOR-SECO- CUCURBIT[n]URIL COMPOUNDS
09/20/2007WO2007105751A1 Quinolone derivative or pharmaceutically acceptable salt thereof
09/20/2007WO2007105023A1 Modulation of phosphoryl transferase activity of glutamine synthetase
09/20/2007WO2007104944A1 Pyrrolopyrimidine derivatives used as hsp90 inhibitors
09/20/2007WO2007104723A1 Porphyrin derivates and their use as photosensitizers in photodynamic therapy
09/20/2007WO2007104685A1 Use of aryl- or alkyloxy-substituted phthalocyanines as marking substances for liquids
09/20/2007WO2007104652A2 Non-peptidic renin inhibitors nitroderivatives
09/20/2007WO2007089768A3 4-aryl-2-amino-pyrimidines or 4-aryl-2-aminoalkyl-pyrimidines as jak-2 modulators and pharmaceutical compositions containing them
09/20/2007WO2006089286A3 Triazadibenzoazulene compounds useful for the treatment and prevention of pain and screening methods therefor compounds useful for the treatment and prevention of pain and screening methods therefor
09/20/2007US20070219369 Process for the Manufacture of fused piperazin-2-one derivatives
09/20/2007US20070219257 Wnt Pathway Antagonists
09/20/2007US20070219220 Pyrazolopyrimidinethione Derivatives, Salts and Solvates Thereof, Preparation Methods and Use Thereof
09/20/2007US20070219205 To treat autoimmune, inflammatory, proliferative, hyperproliferative,neurodegenerative or immunologically-mediated diseases; useful for the study of kinases in biological and pathological phenomena; study of intracellular signal transduction pathways mediated by such kinases, and comparative evaluation
09/20/2007US20070219203 Arylalkylamino-substituted quinazoline analogues
09/20/2007US20070219202 3-(2-alkoxycarbonyl-3-indolyl)-3-oxo-propionic acid ester or propionamide intermediates: methyl 3-[6-fluoro-2-(methoxycarbonyl)-1-methyl-1H-indol-3-yl]-3-oxopropanoate; peripheral neuropathy, Parkinson's disease, Alzheimer's disease
09/20/2007US20070219188 Oxadiazine Derivatives
09/20/2007US20070219186 Pyrazolo[1,5-A]pyrimidine derivatives and methods of use thereof
09/20/2007US20070219183 Dihydropyrazolo[1,5-A]pyrimidine and dihydroimidazo[1,5-A]pyrimidine derivatives and methods of use thereof
09/20/2007US20070219178 Preventive or therapeutic agents for multiple sclerosis
09/20/2007DE102007008940A1 Substituierte Imidazolopyrimidine, Verfahren zu ihrer Herstellung und ihre Verwendung zur Bekämpfung von Schadpilzen sowie sie enthaltende Mittel Substituted imidazolopyrimidines, processes for their preparation and their use for controlling harmful fungi and to compositions comprising
09/20/2007CA2646235A1 Non-peptidic renin inhibitors nitroderivatives
09/20/2007CA2646205A1 Use of aryl- or alkyloxy-substituted phthalocyanines as markers for liquids
09/20/2007CA2646154A1 Piperidinyl, indolyl, pirinidyl, morpholinyl and benzimidazolyl urea derivatives as inhibitors of soluble epoxide hydrolase for the treatment of hypertension, inflammations and other diseases
09/20/2007CA2645711A1 Quinolone derivative or pharmaceutically acceptable salt thereof
09/20/2007CA2645343A1 Pyrrolopyrimidine derivatives used as hsp90 inhibitors
09/20/2007CA2645063A1 Porphyrin derivates and their use as photosensitizers in photodynamic therapy
09/19/2007EP1834955A1 Porphyrin derivates and their use as photosensitizers in photodynamic therapy
09/19/2007EP1833477A1 Pyrazolo-heteroaryl compounds useful to treat tnf-alpha and il-1 mediated diseases
09/19/2007EP1680426B1 1.3.4-triaza-phenalene and 1,3,4,6-tetraazaphenalene derivatives
09/19/2007EP1655301A4 Cyclic bioisosters of purine system derivatives and a pharmaceutical composition based thereon
09/19/2007EP1496907B1 Tyrosine kinase inhibitors
09/19/2007EP1490335B1 Beta-amino heterocyclic dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes
09/19/2007EP1439841B1 Androgen receptor modulators and methods of use thereof
09/19/2007EP1296982B1 1-(heteroaryl-phenyl)-condensed pyrazol derivatives as factor xa inhibitors
09/19/2007CN101039947A Inhibitors of hcv replication
09/19/2007CN101039946A Disubstituted pyrazolobenzodiazepines useful as inhibitors for cdk2 and angiogesis, and for the treatment of breast, colon, lung and prostate cancer
09/19/2007CN101039945A Pyrazolo[1,5-a]pyrimidine derivatives
09/19/2007CN101039933A Diaminotriazole compounds useful as protein kinase inhibitors
09/19/2007CN101039916A Imidazole derivatives as large conductance calcium activated K channel openers
09/19/2007CN101039718A Cgrp受体拮抗剂 Cgrp receptor antagonists
09/19/2007CN100338074C Heterocyclic compounds and cerebral function improvers containing same as active
09/19/2007CN100338050C Amine acid salt compounds and process for the production thereof
09/19/2007CN100338047C Process for the preparation of pyrazolopyrimidin ones
09/19/2007CN100338040C Xanthine oxidase inhibitors
09/18/2007US7271262 Antiproliferative agents
09/18/2007US7271172 Pyrrolidine and azetidine compounds as CCR5 antagonists
09/18/2007US7271171 Adenosine A3 receptor modulators
09/18/2007US7271170 Imidazo-pyrimidines and triazolo-pyrimidines: benzodiazepine receptor ligands
09/18/2007US7271168 Piperazine derivatives having SST1 antagonistic activity
09/18/2007US7271164 Therapy , prevention of obsessive-complusive disorders; antidepressants; anxiety; schizophrenia; eating disorders; obesity; antiepileptic agents central nervous system disorders; sleep disorders
09/18/2007US7271163 Cyclopenta[b][1,4]diazepino[6,7,1-hi]indoles and derivatives
09/18/2007US7271162 Cycloocta[b][1,4]diazepino[6,7,1-hi]indoles and derivatives
09/18/2007CA2417106C Piperazine derivatives
09/18/2007CA2411957C Novel process for the preparation of pyrazolopyrimidinones
09/18/2007CA2329077C Pyrazolopyrimidinone cgmp pde5 inhibitors for the treatment of sexual dysfunction
09/13/2007WO2007103905A2 Prolyl hydroxylase inhibitors
09/13/2007WO2007103706A2 Nanoparticulate probe for in vivo monitoring of tissue oxygenation
09/13/2007WO2007102580A1 Polycyclic cinnamide derivative
09/13/2007WO2007102531A1 Pharmaceutical combination
09/13/2007WO2007101871A1 Substituted imidazolopyrimidines, method for the production thereof and use thereof for controlling parasitic fungi and agents containing the latter
09/13/2007WO2007101870A1 Substituted triazolopyrimidines, methods for the production thereof and use thereof for controlling parasitic fungi and agents containing the latter
09/13/2007WO2007101859A1 Substituted pyrazolopyrimidines, method for the production thereof and use thereof for controlling parasitic fungi and agents containing the latter
09/13/2007WO2007101810A1 Substituted triazolopyrimidines, methods for the production thereof and use thereof for controlling parasitic fungi and agents containing the same
09/13/2007WO2007101804A1 Substituted pyrazolopyrimidines, methods for the production thereof and use thereof for controlling parasitic fungi and agents comprising the same
09/13/2007WO2007101606A1 Thiosulfonate anti-inflammatory agents
09/13/2007WO2007087283A3 Thiophene-carboxamides useful as inhibitors of protein kinases
09/13/2007WO2007011445A3 Synergistic composition and method for inhibiting growth of microorganisms
09/13/2007US20070213529 Process for the Manufacture of fused piperazin-2-one derivatives
09/13/2007US20070213527 Organometal complex and light-emitting element using the same
09/13/2007US20070213362 2-nh-heteroarylimidazoles with antibacterial activity
09/13/2007US20070213352 Pyridine-containing macroheterococylic compounds as kinase inhibitors
09/13/2007US20070213338 Triazolo-Pyridazine Compounds and Derivatives Thereof Useful in the Treatment of Neuropathic Pain
09/13/2007US20070213337 Modulators of serotonin receptors
09/13/2007US20070213335 Prolyl Hydroxylase Inhibitors
09/13/2007US20070213334 Cannabinoid receptor ligands and uses thereof
09/13/2007US20070213333 Suppress production of both prostaglandins and leukotrienes and have reduced side effects; treatment of various inflammatory diseases, autoimmune diseases, allergic diseases, pain and fibrosis; for example, methyl 3-[3-acetylamino-4-cyclopentyloxy-5-(naphthalen-2-yl)phenyl]propionate
09/13/2007US20070213332 Prodrugs Of Substituted Amino Heterobicycles Which Modulate The Function Of The Vanilloid-1 Receptor (Vr1)
09/13/2007US20070213316 N,N'-substituted-1,3-diamino-2-hydroxypropane derivatives
09/13/2007US20070213300 Pyrrolotriazine aniline prodrug compounds useful as kinase inhibitors
09/13/2007DE102007008939A1 Substituierte Imidazolopyrimidine, Verfahren zu ihrer Herstellung und ihre Verwendung zur Bekämpfung von Schadpilzen sowie sie enthaltende Mittel Substituted imidazolopyrimidines, processes for their preparation and their use for controlling harmful fungi and to compositions comprising
09/13/2007CA2645031A1 Pyrrolotriazine aniline prodrug compounds useful as kinase inhibitors
09/13/2007CA2645018A1 Pharmaceutical combination
09/13/2007CA2643796A1 Polycyclic cinnamide derivatives
09/13/2007CA2643362A1 Use of pyrazolo[1,5a]pyrimidin-7-yl amine derivatives in the treatment of neurological disorders
09/12/2007EP1832591A1 12-position substituted mutilin derivative
09/12/2007EP1832590A2 Tri- heterocyclic compounds and a pharmaceutical comprising them as an active ingredient
09/12/2007EP1832589A1 Inhibitors of cyclin-dependent kinases,compositions and uses related thereto